GritBIO is the solution to the next generation of cancer therapeutics. Through the development of peptide technologies, which target the metabolism of cancer, GritBIO is able to offer a safer approach to treating squamous cell carcinoma of the pharynx. GritBIO is also currently researching novel biological inhibitors for SARS-CoV-2. The research currently being conducted positions our company at the cutting edge of solutions for today's most salient problems.
Company Details
- Founded
- -
- Address
- 400 W 128th St,
- Industry
- Research
- Website
- https://www.gritbio.com/
- Keywords
- New York.
- HQ
- Manhattan, NY
Grit Bio, Inc. Questions
Grit Bio, Inc.'s website is https://www.gritbio.com/
Grit Bio, Inc.'s LinkedIn profile is https://www.linkedin.com/company/gritbio-inc
Grit Bio, Inc.'s industry is
Research
Grit Bio, Inc.'s categories are Research
Grit Bio, Inc.'s founding year is 2017
